M Weil

1.5k total citations
69 papers, 1.1k citations indexed

About

M Weil is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, M Weil has authored 69 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Public Health, Environmental and Occupational Health and 19 papers in Hematology. Recurrent topics in M Weil's work include Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (17 papers) and Cancer Treatment and Pharmacology (15 papers). M Weil is often cited by papers focused on Acute Lymphoblastic Leukemia research (24 papers), Acute Myeloid Leukemia Research (17 papers) and Cancer Treatment and Pharmacology (15 papers). M Weil collaborates with scholars based in France, United States and Austria. M Weil's co-authors include M Boiron, C Jacquillat, G Auclerc, J Bernard, Jean Bernard, D. Khayat, J Tanzer, C Jacquillat, Marie-Françoise Auclerc and Y Najean and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

M Weil

65 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Weil France	16	446	377	374	285	222	69	1.1k
F. R. Appelbaum United States	14	287 0.6×	245 0.6×	552 1.5×	154 0.5×	273 1.2×	25	1.1k
W. Plunkett United States	13	354 0.8×	391 1.0×	448 1.2×	460 1.6×	196 0.9×	21	1.2k
Henderson Es United States	15	227 0.5×	195 0.5×	293 0.8×	157 0.6×	153 0.7×	29	693
H Kantarjian United States	16	310 0.7×	169 0.4×	594 1.6×	310 1.1×	288 1.3×	28	1.2k
WJ Miller United States	12	242 0.5×	178 0.5×	1.0k 2.7×	272 1.0×	137 0.6×	19	1.4k
R. Pieters Netherlands	23	303 0.7×	926 2.5×	837 2.2×	611 2.1×	96 0.4×	41	1.8k
Bertil Uggla Sweden	14	414 0.9×	162 0.4×	600 1.6×	485 1.7×	159 0.7×	31	1.1k
Joanne Lager United States	17	439 1.0×	120 0.3×	296 0.8×	563 2.0×	215 1.0×	37	1.2k
F. Dreyfus France	15	441 1.0×	106 0.3×	645 1.7×	462 1.6×	153 0.7×	56	1.2k
G. Ucci Italy	19	355 0.8×	65 0.2×	463 1.2×	357 1.3×	92 0.4×	61	931

Countries citing papers authored by M Weil

Since Specialization

Citations

This map shows the geographic impact of M Weil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Weil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Weil more than expected).

Fields of papers citing papers by M Weil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Weil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Weil. The network helps show where M Weil may publish in the future.

Co-authorship network of co-authors of M Weil

This figure shows the co-authorship network connecting the top 25 collaborators of M Weil. A scholar is included among the top collaborators of M Weil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Weil. M Weil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Köhler, M., et al.. (2017). Devenir obstétrical après transfusion in utero pour allo-immunisation fœto-maternelle. Gynécologie Obstétrique Fertilité & Sénologie . 46(1). 14–19. 1 indexed citations

Bernard, J, et al.. (2003). Treatment of Acute Leukemias. Humana Press eBooks. 9(2). 181–91. 1 indexed citations

Rixe, Olivier, A. Benhammouda, C Farabos, et al.. (1995). 955 A phase I study of concomitant CPT-11 (C) and 5FU (F) combination: Preliminary results. European Journal of Cancer. 31. S198–S199. 3 indexed citations

Baillet, F, et al.. (1993). Treatment of Locally Advanced Breast Cancer without Mastectomy. Annals of the New York Academy of Sciences. 698(1). 264–270. 10 indexed citations

Weil, M, et al.. (1992). Nonsurgical Approach in Stage I and Stage II Breast Cancer. Cancer Investigation. 10(6). 581–586. 2 indexed citations

Khayat, D., Jean-Pierre Bizzari, M. Frénay, et al.. (1988). Interim Report of Phase II Study of New Nitrosourea S 10036 in Disseminated Malignant Melanoma. JNCI Journal of the National Cancer Institute. 80(17). 1407–1408. 20 indexed citations

Auclerc, G, et al.. (1983). [Acute leukemias and solid tumors in the course of Hodgkin disease].. PubMed. 70(1). 61–6. 3 indexed citations

Weil, M, C Jacquillat, & G Tobelem. (1981). Therapy of Acute Monoblastic Leukemia. Hämatologie und Bluttransfusion. 27. 189–194.

Jacquillat, C, et al.. (1981). [Treatment of acute lymphoblastic leukaemia in children over twenty years (author's transl)].. PubMed. 10(23). 1903–8. 1 indexed citations

10.

Jacquillat, C, M Weil, G Schaison, et al.. (1980). Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemia.. PubMed. 67(4). 458–69. 3 indexed citations

11.

Schaison, G, et al.. (1980). [Acute leukemia in childhood: present status of 100 cases after 7 years of complete remission (author's transl)].. PubMed. 67(3). 261–8. 3 indexed citations

12.

Jacquillat, C, M Weil, J Maral, et al.. (1979). Clinical activity of detorubicin: a new anthracycline derivative.. PubMed. 63(5). 889–93. 6 indexed citations

13.

Tanzer, J, J Brière, M Weil, et al.. (1978). Prognostic factors in chronic granulocytic leukemia. A study of 798 cases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(3). 237–46. 10 indexed citations

14.

Weil, M, et al.. (1976). Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies. Cancer. 37(2). 653–659. 43 indexed citations

15.

Jacquillat, C, M Weil, V. Izraël, et al.. (1972). Treatment of Acute Myeloblastic Leukaemia with RP 22050. BMJ. 4(5838). 468–469. 10 indexed citations

16.

Jacquillat, C, M Weil, G Schaison, et al.. (1971). [Chemotherapy of Hodgkin's disease with drug combinations].. PubMed. 79(12). 513–8. 2 indexed citations

17.

Boiron, M, C Jacquillat, M Weil, et al.. (1969). DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIA. The Lancet. 293(7590). 330–333. 82 indexed citations

18.

Weil, M, et al.. (1969). Combination of arabinosyl cytosine, methylglyoxal bis (guanylhydrazone), 6-mercaptopurine and prednisone in the treatment of acute myelocytic leukemia. European Journal of Cancer (1965). 5(3). 271–275. 14 indexed citations

19.

Dreyfus, B, Sultan C, M Boiron, et al.. (1968). [On attack treatment using rubidomycin in 19 cases of acute myeloblastic leukemia].. PubMed. 76(2). 55–7. 2 indexed citations

20.

Tanzer, J, et al.. (1966). RUBIDOMYCIN. The Lancet. 288(7453). 27–28. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact